loader2
Partner With Us NRI

Company details

108.05
109.55
97.00
196.50
6M Return -14.38%
1Y Return -18.45%
Mkt Cap.(Cr) 172.05
Volume 865
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 865

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 130.96 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 25,587.81 -37,752.78
LAST 3M 74,012.99 -52,283.98
LAST 6M 141,118.09 -186,787.74
LAST 12M 210,989.03 -181,030.70

Information

  • About Company
  • Company Info
  • Listing Info
11.38
50.53%
88.3048
27.4%
23.81%
Description
  • Mangalam Drugs and Organics Ltd is an India-based company. The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates. The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra. They also have an in-house Research and Development (R&D) Base. Their products include chloroquine phosphate I.P., aluminum chloride anhydrous, and dyes and intermediaries. Mangalam Drugs and Organics Ltd was incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. The company was promoted by Dhoot family. The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals. In April 1, 1996 three other group companies, namely Mangalam Organics Pvt Ltd, Shree Mangalam Pharma Pvt Ltd and Mangalam Rasayan Pvt Ltd were amalgamated with the company. In July 1, 1997, the company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. In September 22, 1997, the company was converted into a deemed public company and word `private` was deleted from the company`s name. In the year 1999, the company launched a new product namely, Nimesulide. In the year 2001, they launched two new products namely Amodiaquine Hydrochloride and Amodiaquine. In August 10, 2001, the company was converted into a full fledged public limited company. In the year 2003-2004, the bulk drug production capacity of the Company was increased from 350 MTPA to 600 MTPA. During the 2004-05, the capacity is being further enhanced to 960 MTPA. During the year 2005-06, the company further enhanced their Bulk drug production capacity from 960 MT per annum to 1260 MT per annum. During the year 2007-08, the company developed and introduced new bulk drugs namely Bisoprolol Fumarate and Pantaprazole Sodium. Also, they increased the production capacity of Meta Chloro Aniline & Allied Products from 250 tons to 350 tons. During the year 2009-10, the company in addition to Regulatory Affairs Cell established Intellectual Property Rights (IPR) cell. The regulatory affairs cell submitted 6 DMFs to WHO-Geneva out of which 2 DMFs corresponding to Artemether and Lumefantrine had been approved.

Read More

Registered Address

3rd Floor Rupam Building, 239 P D Mello Road, Mumbai, Maharashtra, 400001

Tel : 91-22-22616200/6300/8787
Email : contactus:mangalamdrugs.com
Website : http://www.mangalamdrugs.com

Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 532637
NSE Code : MANGALAM
Book Closure Date (Month) :
BSE Group : B
ISIN : INE584F01014

ICICIdirect Mangalam Drugs and Organics Ltd FAQ

You can buy Mangalam Drugs and Organics Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Mangalam Drugs and Organics Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 25, 2022 04:01 PM the closing price of Mangalam Drugs and Organics Ltd was ₹ 108.70.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 25, 2022 04:01 PM, the market cap of Mangalam Drugs and Organics Ltd stood at ₹ 172.05.
The latest PE ratio of Mangalam Drugs and Organics Ltd as of May 25, 2022 04:01 PM is 11.38
The latest PB ratio of Mangalam Drugs and Organics Ltd as of May 25, 2022 04:01 PM is 0.81
The 52-week high of Mangalam Drugs and Organics Ltd is ₹ 196.50 while the 52-week low is ₹ 97.00 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE